D-0622-2017 Class II Terminated
FDA drug recall D-0622-2017 was initiated by Mylan Institutional, Inc. (D.B.A. UDL Laboratories) on Mar 21, 2017 and is designated Class II. Reason for recall: Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms. The recall status is terminated (terminated Mar 15, 2019). Affected quantity: 1,527 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 5, 2017
- Initiation Date
- Mar 21, 2017
- Termination Date
- Mar 15, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,527 cartons
Product description
Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20
Reason for recall
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 3084288, Exp. 07/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0622-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026